ENHANCED PROTECTION OF CYCLOPHOSPHAMIDE-TREATED MICE AGAINST INFECTION WITH PSEUDOMONAS-AERUGINOSA AFTER TREATMENT WITH Z-100, A POLYSACCHARIDE-RICH EXTRACT FROM MYCOBACTERIUM-TUBERCULOSIS AOYAMA-B

被引:14
作者
KAWAMURA, I [1 ]
MITSUYAMA, M [1 ]
NOMOTO, K [1 ]
机构
[1] KYUSHU UNIV,MED INST BIOREGULAT,DIV IMMUNOL,FUKUOKA 812,JAPAN
关键词
D O I
10.3109/08923979009006467
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated the effect of Z-100, a polysaccharide-rich extract from Mycobacterium tuberculosis strain Aoyama B, on the protection of immunocompromised mice against infection with Pseudomonas aeruginosa. Mice were given cyclophosphamide and then treated with varying doses of Z-100 for 5 days or left untreated. One day after the completion of the treatment, they were challenged with P. aeruginosa and the mortality was scored. A significantly enhanced protection was observed in the treated group and bacterial number in organs was significantly lower compared with non-treated group. Though the activity of phagocytes did not appear to be activated since there was no difference in chemiluminescence response of peritoneal phagocytes between control and Z-100-treated groups, an enhanced accumulation of phagocytes was observed after bacterial challenge in Z-100-treated group. It was suggested that Z-100 is effective in the restoration of impaired resistance of immunocompromised mice to bacterial infection possibly through a stimulation of phagocyte accumulation into the site of infection. © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:331 / 343
页数:13
相关论文
共 23 条
[1]   STIMULATION OF NON-SPECIFIC ANTI-TUMOR RESISTANCE IN THE MOUSE USING CELL-WALL PREPARATIONS FROM 4 BCG SUBSTRAINS [J].
BEAUDET, R ;
FRENETTE, M ;
PORTELANCE, V .
ANNALES D IMMUNOLOGIE, 1983, C134 (02) :215-226
[2]   ANTIBODY-INDEPENDENT PROTECTION AGAINST PSEUDOMONAS-AERUGINOSA INFECTION IN MICE AFTER TREATMENT WITH A HOMOLOGOUS STRAIN VACCINE [J].
FUJIMURA, T ;
SUZUKI, T ;
MITSUYAMA, M ;
SAITO, H ;
NOMOTO, K .
JOURNAL OF MEDICAL MICROBIOLOGY, 1989, 28 (02) :101-108
[3]   INTERFERON-INDUCING ACTIVITY OF AN IMMUNOTHERAPEUTIC ANTI-CANCER AGENT, SSM, PREPARED FROM MYCOBACTERIUM-TUBERCULOSIS STRAIN AOYAMA-B [J].
HAYASHI, Y ;
EBINA, T ;
SUZUKI, F ;
ISHIDA, N .
MICROBIOLOGY AND IMMUNOLOGY, 1981, 25 (03) :305-316
[4]  
KOBATAKE H, 1988, YAKUGAKU ZASSHI, V101, P713
[5]   INCREASED RESISTANCE TO STAPHYLOCOCCUS-AUREUS INFECTION AND ENHANCEMENT IN SERUM LYSOZYME ACTIVITY BY GLUCAN [J].
KOKOSHIS, PL ;
WILLIAMS, DL ;
COOK, JA ;
DILUZIO, NR .
SCIENCE, 1978, 199 (4335) :1340-1342
[6]  
MATSUMOTO T, 1982, J CLIN LAB IMMUNOL, V8, P51
[7]   T-CELL-INDEPENDENT ACTIVATION OF MACROPHAGES BY VIABLE BCG IN TUMOR-BEARING MICE [J].
MATSUO, K ;
TAKEYA, K ;
NOMOTO, K ;
SHIMOTORI, S ;
TERASAKA, R .
CELLULAR IMMUNOLOGY, 1981, 57 (02) :293-306
[8]   3 PHASES OF PHAGOCYTE CONTRIBUTION TO RESISTANCE AGAINST LISTERIA-MONOCYTOGENES [J].
MITSUYAMA, M ;
TAKEYA, K ;
NOMOTO, K ;
SHIMOTORI, S .
JOURNAL OF GENERAL MICROBIOLOGY, 1978, 106 (MAY) :165-171
[9]  
MIYATA H, 1980, IMMUNOLOGY, V40, P33
[10]  
MOORE MAS, 1986, BLOOD S1, V68, pA173